Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of the Structured Sherborne Developmental Movement Program on Sensory Processing, Motor Performance, and Functional Status in Children With Autism Spectrum Disorder

NCT06766942 is registered in ClinicalTrials.gov with Elif Dilan ATILGAN as lead sponsor.

NCT NCT06766942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06766942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of the Structured Sherborne Developmental Movement Program on Sensory Processing, Motor Performance, and Functional Status in Children With Autism Spectrum Disorder
Lead sponsor
Elif Dilan ATILGAN
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2025
Completion date
November 20, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder